info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
us US: +1-315-636-4233    uk UK: +44-162-237-0614     in IN: +91-826-083-6500
Home » Healthcare » Single-cell Analysis Market Industry Report 2030

Single-cell Analysis Market by Product (Consumables (Beads, Reagents, Microplates, Instrument, Assay Kits (Immunoassays, Cell-based Assays), others)), Application (Medical (Noninvasive Prenatal Diagnosis, IVF, and Circulating Tumor Cell Detection), Research (Cancer, Immunology, Neurology, Stem Cell, Other)), By Geography, Size and Forecast, 2021-2030

Published On: Mar-2022   |   Base Year: 2021   |   No Of Pages: 135   |   Historical Data: 2015 - 2019   |   Formats: PDF   |   Report ID: 23566776

Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Product Type & Application

The global single-cell analysis market will witness a robust CAGR of 15.6%, valued at $2.79 billion in 2021, expected to appreciate and reach $10.31 billion by 2030, confirms Strategic Market Research. 

 

Market Drivers

  • With the growing use of technologies and devices like Single-cell sequencing technologies, single-cell sequencing, Single-cell transcriptomics, In Situ Hybridization, fluorescence-based detection devices, fluorescence biosensors, FRET biosensors, and mass spectroscopy, the market for single-cell analysis is expected to grow exponentially.

  • A thorough research study on single-cell genomics, Proteomics, and Metabolomics has led to a number of solutions for proteins, small molecules, and the genetic complement of an organism, which is driving the market growth significantly.

  • Factors such as growing focus on personalized medicine, technological advancements in single-cell analysis products, increased R&D in the single-cell analysis field, rapid progress in the healthcare segment worldwide, and partnership among the key players are expected to propel the single-cell analysis industry in the coming years.

single cell analysis market by share 2020-2028

Market Restraint

  • In maintaining the high-quality standards (i.e., the use of high-grade expensive items) and abiding by the regulatory rules, the single-cell biology research proves to be highly expensive, which is obstructing the market growth.

 

Market Opportunity

  • Various significant market companies invest substantial money in creating solutions, resulting in a profitable revenue generation prospect shortly.

  • Growth in stem cell research is projected to bring profitable opportunities to the market.

single cell analysis market by product 2020-2028

Market Analysis Of Different Segments Covered in the Report

By Product

  • Consumables

    • Beads

    • Reagents

    • Microplates

    • Instruments

    • Assay Kits

      • Immunoassays

      • Cell-based Assays

    • Other Consumables

 

By Application

  • Medical Applications

    • Noninvasive Prenatal Diagnosis

    • in Vitro Fertilization

    • Circulating Tumor Cell Detection

 

  • Research Applications

    • Cancer

    • Immunology

    • Neurology

    • Stem Cell

    • Other Research Applications

 

Regional Coverage Analysis

North America

  • U.S.

  • Canada

  • Mexico

 

Europe

  • Germany

  • France

  • Italy

  • Switzerland

  • UK

  • Rest of Europe

 

Asia-Pacific

  • Japan

  • China

  • India

  • Rest of Asia-Pacific

 

LAMEA

  • Brazil

  • Israel

  • South Africa

  • Saudi Arabia

  • Rest of LAMEA

single cell analysis market by region 2020-2028

 

In 2020, the consumables category dominated the single-cell analysis market, accounting for 67.4 per cent of total market revenue. The profound share of this segment is attributed to the fact that these products are purchased regularly compared to instruments, which are regarded as a one-time investment. Consumables' myriad uses in research and genetic exploration, exosome analysis, and RNA and DNA separation are also likely to propel market expansion. On the other hand, the instruments section generated a greater revenue by installing new instruments and replacing old equipment. The automated devices contributed to the market's considerable revenue due to their high-end features and technically advanced analysis alternatives.

 

Over the forecasted period, the research applications segment is expected to grow at a healthy pace. Due to the increase in the cases of cancer and the growing need for stem cell research, initiatives for early identification of chronic diseases, and increasing awareness of commercially available cancer diagnostics and precision medicine, the research applications segment is expected to hold the largest single-cell analysis market share.

 

In 2020, North America held the largest share of the worldwide single-cell analysis market, accounting for 44.9 per cent. Increased personal healthcare expenditures, high government financing, rapid adoption of novel analytical techniques, and improved awareness contributed to this. The USA is a significant contributor to North America's dominance. Exceptionally well-developed healthcare infrastructure, increased spending on personalized medicine, increased government, and private support, and the rise of public awareness for research projects are some of the market's primary driving forces. Moreover, several government programs have been established in recent years to augment the region's growth. For instance, the NIH (National Institutes of Health) launched the Human Biomolecular Atlas Program (HuBAP) in 2018 to create a dataset with molecular profiles of proteins that can aid in the identification of specific cell types.

 

Moreover, factors including the medical tourism business, rising disposable income, and fast-improving healthcare infrastructure have augmented the demand for modern diagnostic technologies in Asia Pacific's emerging nations in recent years. As a result, the region's market is driven by concentrated efforts, with the greatest CAGR during the projection period. Furthermore, the region's high incidence of chronic disorders such as cancer is propelling the single-cell analysis market expansion. According to the Globocan 2020 report, the United States will see 2,281,658 new cancer cases diagnosed in 2020, with almost 612,390 deaths. Breast (253,465), prostate (209,512), lung (227,875), and colon (101,809) were the most common malignancies in the United States in 2020.

 

Global Single-cell Analysis Market Competitive Landscape Analysis

The list of the Key Market Players is as follows:

 

Single-cell Analysis Market Report Coverage

Report Attribute

Details

Forecast Period

2021 - 2030

The market size value in 2021

USD 2.79 billion

The revenue forecast in 2030

USD 10.31 billion

Growth rate

CAGR of approximately 15.6 %

The base year for estimation

2021

Historical data

2017 – 2020

Unit

USD Billion, CAGR (2021 - 2030)

Segmentation

By Product, By Application, By Region

By Product

Consumables, Beads, Microplates, Reagents, Assay Kits (Immunoassays, Cell-based Assays), Other

By Application

Research Applications (Cancer, Immunology, Neurology, Stem Cell, Other Research Applications), Medical Applications (Noninvasive Prenatal Diagnosis, in Vitro Fertilization, Circulating Tumor Cell Detection)

By Region

North-America, Asia-Pacific, Europe, LAMEA

Country Scope

United States of America, Mexico, United Arab Emirates, United Kingdom, Germany, France, Canada, China, India, Japan, South Korea, Brazil, Argentina, Saudi Arabia, South Africa

Company Usability Profiles

Thermo Fisher Scientific Inc., QIAGEN NV, Bio-Rad Laboratories Inc., Illumina Inc., Merck Millipore, Becton, Dickinson & Company, Fluidigm Corporation, 10x Genomics, Inc., BGINovogene Corporation

 

Recent Developments

  • In April 2020, Mission Bio Inc. and Agilent Technologies Inc. signed a co-marketing agreement to boost the commercialization of Mission Bio's Tapestri Platform. This multi-omic device analyses DNA and protein at the single-cell level.

  • In April 2020, Bio-Rad Laboratories, Inc. finalized the acquisition of Celsee, Inc, a single-cell analysis solution provider, extending its precision medicine and single-cell analysis product range.

Frequently Asked Question About This Report

The major players operating in the market are Thermo Fisher Scientific Inc., QIAGEN NV, Bio-Rad Laboratories Inc., Illumina Inc., Merck Millipore, Becton, Dickinson & Company, Fluidigm Corporation, 10x Genomics, Inc., BGI, Novogene Corporation

The global single cell analysis market size was $2.79 billion in 2021 and is predicted to reach $10.31 billion by 2030, with a CAGR of 15.6%.

The Research Applications segment is the leading Application for the Single-Cell Analysis Market.

North America held the maximum share of the marketin 2020.

The major players operating in the market are Thermo Fisher Scientific Inc., QIAGEN NV, Bio-Rad Laboratories Inc., Illumina Inc., Merck Millipore, Becton, Dickinson & Company, Fluidigm Corporation, 10x Genomics, Inc., BGI, Novogene Corporation.

The consumables market segment is the leading Product for the market.

The global single cell analysis market is expected to grow at a compound annual growth rate (CAGR) of 15.6% from 2021 to 2030 to reach USD $ 10.31 billion by 2030.

Sources

https://www.mybeckman.in/news/cytoflex-srt-benchtop-cell-sorter--wins-selectscience-award

 

1.   Introduction

       1.1.  Study Objective

       1.2.  Market Definition        

       1.3.  Study Scope

              1.3.1. Markets Covered

              1.3.2. Geographic Scope

              1.3.3. Years Considered

              1.3.4. Stakeholders

2.   Research Methodology

       2.1.  Data Procurement

       2.2.  Paid Database

              2.2.1. Secondary Data

                     2.2.1.1. Key Secondary sources

              2.2.2. Primary Data

                     2.2.2.1 Primary sources

                     2.2.2.2. Key industry insights

                     2.2.2.3. Primary interviews with experts

                     2.2.2.4. Key primary respondent list

       2.3.  Market Size Estimation

       2.4.  Bottom-Up and Top-Down Approaches

              2.4.1.       Bottom-Up Approach

                     2.4.1.1.            Approach for arriving at market size by bottom-up analysis

              2.4.2.       Top-Down Approach

                     2.4.2.1.            Approach for Capturing Market Size by Top-Down Analysis

       2.5.  Market Breakdown and Data Triangulation

       2.6.  Research Methodology

       2.7.  Risk Assessment

3.  Executive Summary

       3.1   Post-Covid-19

              3.1.1        Actual Scenario

              3.1.2        Pessimistic Scenario

              3.1.3        Optimistic Scenario

              3.1.4        Market Summary

4. Industry Outlook

       4.1   Market Snapshot

       4.2   Global Single Cell Analysis Market

              4.2.1        Global  market, 2021 – 2030 (USD Million)

       4.3   Regional Business Analysis

              4.3.1        Global  market, by Region, 2021 - 2030 (USD Million)

       4.4   Product Business Analysis

              4.4.1        Global  market,  By Product, 2021 - 2030 (USD Million)

       4.5   Application Business Analysis

              4.5.1        Global  market, By Application, 2021 - 2030 (USD Million)

       4.6   Value Chain Analysis

       4.7   Market Variable Analysis

              4.7.1        Market Drivers Analysis

              4.7.2        Market Restraints Analysis

       4.8   Business Environment Analysis Tool

              4.8.1         market PEST analysis

              4.8.2         market Porter’s analysis

       4.9   Penetration & Growth Prospect Mapping

5. Market Dynamics

       5.1.  Introduction

       5.2.  Market Dynamics

              5.2.1.       Drivers

              5.2.2.       Restraints

              5.2.3.       Opportunities

              5.2.4.       Challenges

       5.3.  Impact of Covid-19 On  Market

       5.4.  Value Chain Analysis

       5.5.  Ecosystem

       5.6.  Patent Analysis

       5.7.  Trade Analysis

       5.8.  Tariff Analysis

       5.9.  Case Study Analysis

5.10.      Porter’s Five Forces Analysis

              5.10.1      Threat of New Entrants

              5.10.2      Threat of Substitutes

              5.10.3      Bargaining Power of Buyers

              5.10.4      Bargaining Power of Suppliers

              5.10.5      Degree of Competition

       5.11.               Technology Analysis

              5.11.1.     Trends in Technology (2014-2021)

              5.11.2.     Trends in Technology (2021-2030)

       5.12.               Pricing Analysis

              5.12.1.     Average Price Trend Analysis (By Region, By Country)

6. Competitive & Vendor Landscape

       6.1.  Company Market Share Analysis

       6.2.  Manufacturers  Manufacturing Sites, Area Served, Product

       6.3.   Market Competitive Situation and Trends

       6.4.  Manufacturers Mergers & Acquisitions, Expansion Plans

7. Global  Market:  By Product Segment Analysis

       7.1.  Introduction

       7.2.  Sales Volume & Revenue Analysis (2021-2030)

       7.3.  Consumables

              7.3.1. Consumables market, 2021 - 2030 (USD Million)

                     7.3.1.1 Beads market, 2021 - 2030 (USD Million)

                     7.3.1.2 Microplates market, 2021 - 2030 (USD Million)

                     7.3.1.3 Reagents market, 2021 - 2030 (USD Million)

                     7.3.1.4 Assay Kits market, 2021 - 2030 (USD Million)

                            7.3.1.4.1 Immunoassays market, 2021 - 2030 (USD Million)

                            7.3.1.4.2 Cell-based Assays market, 2021 - 2030 (USD Million)

                      7.3.1.5 Other Consumables market, 2021 - 2030 (USD Million)

       7.4 Instruments

             7.4.1 Instruments market, 2021 - 2030 (USD Million)

8. Global  Market: By Application Segment Analysis

       8.1. Introduction

       8.2. Sales Volume & Revenue Analysis (2021-2030)

       8.3. Research Applications

              8.3.1. Research Applications market, 2021 - 2030 (USD Million)

                     8.3.1.1 Cancer market, 2021 - 2030 (USD Million)

                     8.3.1.2 Immunology market, 2021 - 2030 (USD Million)

                     8.3.1.3 Neurology market, 2021 - 2030 (USD Million)

                     8.3.1.4 Stem Cell market, 2021 - 2030 (USD Million)

                     8.3.1.5 Other Research Applications market, 2021 - 2030 (USD Million)

8.4. Medical Applications

              8.4.1. Medical Applications market, 2021 - 2030 (USD Million)

                     8.4.1.1 Noninvasive Prenatal Diagnosis market, 2021 - 2030 (USD Million)

                     8.4.1.2 in Vitro Fertilization market, 2021 - 2030 (USD Million)

                     8.4.1.3 Circulating Tumor Cell Detection market, 2021 - 2030 (USD Million)

9. Global  Market: Regional Outlook

       9.1   North America

              9.1.1.       North America  market, By Product, 2021 - 2030 (USD Million)

              9.1.4.       North America  market, By Application, 2021 - 2030 (USD Million)

 

              9.1.5.       North America  market, by Country, 2021 - 2030 (USD Million)

9.1.4.1. U.S.

                     9.1.4.1.1.         U.S.  market, By Product, 2021 - 2030 (USD Million)

    9.1.4.2.      Canada

                     9.1.4.2.1.         Canada  market, By Product, 2021 - 2030 (USD Million)

                     9.1.4.2.2.         Canada  market, By Region, 2021 - 2030 (USD Million)

                     9.1.4.2.3.         Canada  market, by Applications, 2021 - 2030 (USD Million)

9.2.         Europe

              9.2.1.       Europe  market, By Product, 2021 - 2030 (USD Million)

              9.2.2.       Europe  market, by  By Application, 2021 - 2030 (USD Million)

              9.2.5.       Europe  market, by country, 2021 - 2030 (USD Million)

    9.2.4.1    U.K.

                     9.2.4.1.1.         U.K.  market, By Product, 2021 - 2030 (USD Million)

                     9.2.4.1.2.         U.K.  market, By Applications, 2021 - 2030 (USD Million)

                     9.2.4.1.3.         U.K.  market, by Region, 2021 - 2030 (USD Million)

   9.2.4.2.              Germany

                     9.2.4.2.1.         Germany  market, By Product, 2021 - 2030 (USD Million)

                     9.2.4.2.2.         Germany  market, By Application, 2021 - 2030 (USD Million)

                     9.2.4.2.3.         Germany  market, by Region, 2021 - 2030 (USD Million)

   9.2.4.3.              France

                     9.2.4.3.1.         France  market, By Product, 2021 - 2030 (USD Million)

                     9.2.4.3.2.         France  market, By Region, 2021 - 2030 (USD Million)

                     9.2.4.3.3.         France  market, by Application, 2021 - 2030 (USD Million)

    9.2.4.4.             Rest of Europe

                     9.2.4.4.1.         Rest of Europe  market, By Product, 2021 - 2030 (USD Million)

                     9.2.4.4.2.         Rest of Europe  market, By Region, 2021 - 2030 (USD Million)

                     9.2.4.4.3.         Rest of Europe  market, by Application, 2021 - 2030 (USD Million)

       9.3.  Asia Pacific

              9.3.1.       Asia Pacific  market, By Product, 2021 - 2030 (USD Million)

              9.3.2.       Asia Pacific  market, By Application, 2021 - 2030 (USD Million)

              9.3.5.       Asia Pacific  market, by country, 2021 - 2030 (USD Million)

   9.3.4.1.              China

                     9.3.4.1.1.         China  market, By Product, 2021 - 2030 (USD Million)

                     9.3.4.1.2.         China  market, By Region, 2021 - 2030 (USD Million)

                     9.3.4.1.3.         China  market, by Application, 2021 - 2030 (USD Million)

   9.3.4.2.              India

                     9.3.4.2.1.         India  market, By Product, 2021 - 2030 (USD Million)

                     9.3.4.2.2.         India  market, By Region, 2021 - 2030 (USD Million)

                     9.3.4.2.3.         India  market, by Application, 2021 - 2030 (USD Million)

   9.3.4.3.              Japan

                     9.3.4.3.1.         Japan  market, By Product, 2021 - 2030 (USD Million)

                     9.3.4.3.3.         Japan  market, by Application, 2021 - 2030 (USD Million)

   9.3.4.4.              South Korea

                     9.3.4.4.1.         South Korea  market, By Product, 2021 - 2030 (USD Million)

                     9.3.4.4.3.         South Korea  market, by Application, 2021 - 2030 (USD Million)

9.3.4.5.             Rest of ASIA PACIFIC

                     9.3.4.5.1.         Rest of ASIA PACIFIC  market, By Product, 2021 - 2030 (USD Million)

                     9.3.4.5.3.         Rest of ASIA PACIFIC  market, by Application, 2021 - 2030 (USD Million)

       9.4.  Latin America

              9.4.1.       Latin America  market, By Product, 2021 - 2030 (USD Million)

              9.4.3.       Latin America  market, by Application, 2021 - 2030 (USD Million)

              9.4.4.       Latin America  market, by country, 2021 - 2030 (USD Million)

9.4.4.1. Brazil

                     9.4.4.1.1.         Brazil  market, By Product, 2021 - 2030 (USD Million)

                     9.4.4.1.3.         Brazil  market, by Application, 2021 - 2030 (USD Million)

9.4.4.2. Mexico

                     9.4.4.2.1.         Mexico  market, By Product, 2021 - 2030 (USD Million)

                     9.4.4.2.3.         Mexico  market, by Application, 2021 - 2030 (USD Million)

  9.4.4.3.               Rest of the Latin America

                     9.4.4.3.1.         Rest of the Latin America  market, By Product, 2021 - 2030 (USD Million)

                     9.4.4.3.3.         Rest of the Latin America  market, by Application, 2021 - 2030 (USD Million)

10. Competitive Landscape

       10.1 Thermo Fisher Scientific Inc.

              10.1.1.     Company overview

              10.1.2.     Financial performance

              10.1.3.     Product Portfolio Analysis

              10.1.4.     Business Strategy & Recent Development

       10.2. QIAGEN NV

              10.2.1.     Company overview

              10.2.2.     Financial performance

              10.2.3.     Product Portfolio Analysis

              10.2.4.     Business Strategy & Recent Development

       10.3. Bio-Rad Laboratories Inc. 

              10.3.1.     Company overview

              10.3.2.     Financial performance

              10.3.3.     Product Portfolio Analysis

              10.3.4.     Business Strategy & Recent Development

       10.4. Illumina Inc.

              10.4.1.     Company overview

              10.4.2.     Financial performance

              10.4.3.     Product Portfolio Analysis

              10.4.4.     Business Strategy & Recent Development

       10.5. Merck Millipore.

              10.5.1.     Company overview

              10.5.2.     Financial performance

              10.5.3.     Product Portfolio Analysis

              10.5.4.     Business Strategy & Recent Development

       10.6. Becton.

              10.6.1.     Company overview

              10.6.2.     Financial performance

              10.6.3.     Product Portfolio Analysis

              10.6.4.     Business Strategy & Recent Development

       10.7. Dickinson & Company.

              10.7.1.     Company overview

              10.7.2.     Financial performance

              10.7.3.     Product Portfolio Analysis

              10.7.4.     Business Strategy & Recent Development

       10.8. Fluidigm Corporation.

              10.8.1.     Company overview

              10.8.2.     Financial performance

              10.8.3.     Product Portfolio Analysis

              10.8.4.     Business Strategy & Recent Development

       10.9. 10x Genomics, Inc.

              10.9.1.     Company overview

              10.9.2.     Financial performance

              10.9.3.     Product Portfolio Analysis

              10.9.4.     Business Strategy & Recent Development

       10.10. BGI.

              10.10.1.  Company overview

              10.10.2.  Financial performance

              10.10.3.  Product Portfolio Analysis

              10.10.4.  Business Strategy & Recent Development

       10.11. Novogene Corporation.

              10.11.1.  Company overview

              10.11.2.  Financial performance

              10.11.3.  Product Portfolio Analysis

              10.11.4.  Business Strategy & Recent Development

 

List of Tables (42 Tables)

TABLE 1.   MARKET,  By Product, 2021-2030 (USD Million)

TABLE 2.   MARKET  FOR Consumables, BY REGION, 2021-2030 (USD Million)

TABLE 3.   MARKET FOR Other Consumables, BY REGION, 2021-2030 (USD Million)

TABLE 4.  MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 5.  MARKET FOR Research Applications, BY REGION, 2021-2030 (USD Million)

TABLE 6.  MARKET FOR Medical Applications, BY REGION, 2021-2030 (USD Million)

TABLE 7.  MARKET, BY REGION, 2021-2030 (USD Million)

TABLE 8. NORTH AMERICA  MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 9. NORTH AMERICA  MARKET, BY Applications, 2021-2030 (USD Million)

TABLE 10. NORTH AMERICA  MARKET,  By Product, 2021-2030 (USD Million)

TABLE 11. NORTH AMERICA  MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 12. EUROPE  MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 13. EUROPE  MARKET,  By Product, 2021-2030 (USD Million)

TABLE 14. EUROPE  MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 15. ASIA-PACIFIC  MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 16. ASIA-PACIFIC  MARKET,  By Product, 2021-2030 (USD Million)

TABLE 17. ASIA-PACIFIC  MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 18. LAMEA  MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 19. LAMEA  MARKET,  By Product, 2021-2030 (USD Million)

TABLE 20. LAMEA  MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 21. Thermo Fisher Scientific Inc: COMPANY SNAPSHOT

TABLE 22. Thermo Fisher Scientific Inc: OPERATING SEGMENTS

TABLE 23. QIAGEN NV: COMPANY SNAPSHOT

TABLE 24. QIAGEN NV: OPERATING SEGMENTS

TABLE 25. Bio-Rad Laboratories Inc: COMPANY SNAPSHOT

TABLE 26. Bio-Rad Laboratories Inc: OPERATING SEGMENTS

TABLE 27. Illumina Inc: COMPANY SNAPSHOT

TABLE 28. Illumina Inc: OPERATING SEGMENTS

TABLE 29. Merck Millipore: COMPANY SNAPSHOT

TABLE 30. Merck Millipore: OPERATING SEGMENTS

TABLE 31. Becton: COMPANY SNAPSHOT

TABLE 32. Becton: OPERATING SEGMENTS

TABLE 33. Dickinson & Company: COMPANY SNAPSHOT

TABLE 34. Dickinson & Company: OPERATING SEGMENTS

TABLE 35. Fluidigm Corporation: COMPANY SNAPSHOT

TABLE 36. Fluidigm Corporation: OPERATING SEGMENTS

TABLE 37. 10x Genomics, Inc: COMPANY SNAPSHOT

TABLE 38. 10x Genomics, Inc: OPERATING SEGMENTS

TABLE 39. BGI: COMPANY SNAPSHOT

TABLE 40. BGI: OPERATING SEGMENTS

TABLE 41. Novogene Corporation: COMPANY SNAPSHOT

TABLE 42. Novogene Corporation: OPERATING SEGMENTS

 

List of Figures (20 Figures)

Figure 1  Market: Research Methodology Steps

Figure 2 Research Design

Figure 3 Breakdown of Primaries:  Market

Figure 4 Research Methodology: Hypothesis Building

Figure 5  Market: Product-Based Estimation

Figure 6 Top 11 Companies with Highest No. Of Patent in Last 9 Years

Figure 7 No. Of Patents Granted Per Year, 2019–2021

Figure 8 Import Data for Single Cell Analysis, By Country, 2016–2021 (USD Thousand)

Figure 9 Export Data for Single Cell Analysis, By Country, 2016–2021 (USD Thousand)

Figure 10 Data Triangulation Methodology

Figure 11  Market, By Applications, 2019 vs. 2025 (USD Million)

Figure 12  Market Share, By Product, 2019 vs. 2025

Figure 13 Geographical Snapshot of the  Market

Figure 14 Consumables to Witness Higher CAGR in  Market for Product Segment during Forecast Period.

Figure 15 Research Applications to Witness Higher CAGR in  Market for Application Segment during Forecast Period.

Figure 16 North America Accounted for the Largest Share of the  Market, By Regional Basis, in 2019

Figure 17  Market: Drivers, Restraints, Opportunities, and Challenges

Figure 18 North America:  Market Snapshot

Figure 19 Asia Pacific:  Market Snapshot

Figure 20 Vendor Dive: Evaluation Overview